Skip to main content

How is Activase (alteplase) given/administered?

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 8, 2024.

Official Answer by Drugs.com

How Activase is given or administered depends upon the patient’s weight and what it is being used to treat (such as a stroke, pulmonary embolism, or myocardial infarction). For example, when used to treat a heart attack (myocardial infarction), there are two Activase dose regimens, an accelerated and a 3-hour regimen, with different recommendations depending on if the patient is over 67kg or not.

FDA-approved indications for Activase include pulmonary embolism, myocardial infarction with ST-segment elevation (STEMI), ischemic stroke when given within 3 hours of the start of symptoms, and re-establishment of patency in occluded intravenous (IV) catheters.

Recommended administration of Activase for pulmonary embolism (PE)

Recommended administration of Activase for myocardial infarction with ST-segment elevation (STEMI) (heart attack)

Accelerated regimen

Related questions

3-hour regimen

Recommended administration of Activase for Acute Ischemic Stroke

Recommended administration of Activase for IV Catheter Occlusion


References
  • Activase (alteplase) Updated 10/2020. Genentech, Inc. https://www.drugs.com/pro/activ

Read next

What is the difference between Leqvio and Repatha?

Leqvio and Repatha are both injectable medicines that are used for the treatment of high cholesterol, by specifically lowering low density lipoprotein (LDL) levels. Although they both inhibit PCSK9 they work by different mechanisms. Repatha is a monoclonal antibody that binds directly to PCSK9 in the liver preventing it from binding to LDL receptors. Leqvio blocks the PCSK9 protein by interfering with the translation of PCSK9 messenger RNA. Both have the same result – and that is freeing up LDL receptors on the surface of liver cells which allows LDL cholesterol to be removed from the blood.

Continue reading

Is Brilinta a blood thinner or antiplatelet?

Brilinta (generic name: ticagrelor) is an oral antiplatelet prescription tablet for adults that is usually taken twice a day, in the morning and the evening. It is classified as a P2Y12 inhibitor and works by making your platelets less sticky to help prevent blood clots from forming. Continue reading

How does Praluent work?

Praluent works by inactivating a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9). When Praluent inactivates PCSK9, more receptors are available to capture LDL (“bad”) cholesterol for removal from the blood. Lowering LDL in the blood can help to reduce the incidence of heart disease. Continue reading

See also:

Related medical questions

Drug information

Related support groups